SREBF1 and metabolic dysfunction-associated steatotic liver disease: This study could be comprehended that RTLW decreased FAS expressions via suppressing the expression of SREBP1 to reduce TG production in liver and subsequently ameliorate NAFLD in HFD/STZ‐induced T2DM rats.